| Comparative survival and economic benefits of deceased donor kidney transplantation and dialysis in people with varying ages and co-morbidities G Wong, K Howard, JR Chapman, S Chadban, N Cross, A Tong, ... PloS one 7 (1), e29591, 2012 | 239 | 2012 |
| A novel hypoxia-inducible factor− prolyl hydroxylase inhibitor (GSK1278863) for anemia in CKD: a 28-day, phase 2A randomized trial RA Brigandi, B Johnson, C Oei, M Westerman, G Olbina, J De Zoysa, ... American Journal of Kidney Diseases 67 (6), 861-871, 2016 | 176 | 2016 |
| Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients P Hill, NB Cross, ANR Barnett, SC Palmer, AC Webster Cochrane Database of Systematic Reviews, 2017 | 150 | 2017 |
| Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials NB Cross, AC Webster, P Masson, PJ O'connell, JC Craig Transplantation 88 (1), 7-18, 2009 | 139 | 2009 |
| Global transplantation COVID report March 2020 C Ahn, H Amer, D Anglicheau, NL Ascher, CC Baan, G Battsetset, ... Transplantation 104 (10), 1974-1983, 2020 | 112 | 2020 |
| Treatment for peritoneal dialysis‐associated peritonitis AE Ballinger, SC Palmer, KJ Wiggins, JC Craig, DW Johnson, NB Cross, ... Cochrane Database of Systematic Reviews, 2014 | 109 | 2014 |
| Antihypertensive treatment for kidney transplant recipients NB Cross, AC Webster, P Masson, PJ O'Connell, JC Craig Cochrane Database of Systematic Reviews, 2009 | 92 | 2009 |
| Infectious disease transmission in solid organ transplantation: donor evaluation, recipient risk, and outcomes of transmission SL White, W Rawlinson, P Boan, V Sheppeard, G Wong, K Waller, ... Transplantation direct 5 (1), e416, 2019 | 84 | 2019 |
| Developing consensus-based priority outcome domains for trials in kidney transplantation: a multinational Delphi survey with patients, caregivers, and health professionals B Sautenet, A Tong, KE Manera, JR Chapman, AN Warrens, ... Transplantation 101 (8), 1875-1886, 2017 | 79 | 2017 |
| Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells BD Hock, KA Mackenzie, NB Cross, KG Taylor, MJ Currie, BA Robinson, ... Nephrology Dialysis Transplantation 27 (1), 402-410, 2012 | 66 | 2012 |
| Health-related quality of life in people across the spectrum of CKD A Krishnan, A Teixeira-Pinto, WH Lim, K Howard, JR Chapman, ... Kidney international reports 5 (12), 2264-2274, 2020 | 58 | 2020 |
| The experiences of commercial kidney donors: thematic synthesis of qualitative research A Tong, JR Chapman, G Wong, NB Cross, P Batabyal, JC Craig Transplant International 25 (11), 1138-1149, 2012 | 56 | 2012 |
| “It was just an unconditional gift.” Self reflections of non‐directed living kidney donors A Tong, JC Craig, G Wong, J Morton, S Armstrong, J Schollum, N Cross Clinical transplantation 26 (4), 589-599, 2012 | 47 | 2012 |
| Dynamic changes in myeloid derived suppressor cell subsets following renal transplant: a prospective study BD Hock, JL McKenzie, NB Cross, MJ Currie Transplant immunology 32 (3), 164-171, 2015 | 31 | 2015 |
| Asking the right question and finding the right answers NB Cross, JC Craig, AC Webster Nephrology 15 (1), 8-11, 2010 | 27 | 2010 |
| Beliefs and attitudes to bowel cancer screening in patients with CKD: a semistructured interview study LJ James, G Wong, JC Craig, A Ju, N Williams, WH Lim, N Cross, A Tong Clinical Journal of the American Society of Nephrology 12 (4), 568-576, 2017 | 26 | 2017 |
| One-time fecal immunochemical screening for advanced colorectal neoplasia in patients with CKD (DETECT study) G Wong, RL Hope, K Howard, JR Chapman, A Castells, SD Roger, ... Journal of the American Society of Nephrology 30 (6), 1061-1072, 2019 | 23 | 2019 |
| A population pharmacokinetic model to predict oxypurinol exposure in patients on haemodialysis DFB Wright, MP Doogue, ML Barclay, PT Chapman, NB Cross, JH Irvine, ... European journal of clinical pharmacology 73, 71-78, 2017 | 20 | 2017 |
| How to get the most from the medical literature: searching the medical literature effectively AC Webster, NB Cross, R Mitchell, JC Craig Nephrology 15 (1), 12-19, 2010 | 15 | 2010 |
| PHI112844 Investigators: A novel hypoxia-inducible factor-prolyl hydroxylase inhibitor (GSK1278863) for anemia in CKD: a 28-day, phase 2A randomized trial RA Brigandi, B Johnson, C Oei, M Westerman, G Olbina, J De Zoysa, ... Am J Kidney Dis 67 (6), 861-871, 2016 | 13 | 2016 |
Jonathan C Craig, Jonathan CraigCollege of Medicine and Public Health, Flinders University在 flinders.edu.au 的电子邮件经过验证
